Clinical Report: Z Optics Reports 6-Month Data for Z+ Virtual Aperture IOL
Overview
Z Optics presented 6-month clinical results for the Z+ Virtual Aperture IOL. The study showed high rates of uncorrected vision and low incidence of glare and halos.
Background
The evaluation of intraocular lenses (IOLs) is critical in cataract surgery, as they significantly impact visual outcomes and patient satisfaction. The Z+ Virtual Aperture IOL aims to provide a continuous range of vision while minimizing common issues associated with multifocal lenses, such as halos and glare.
Data Highlights
| Outcome | Result |
|---|---|
| Uncorrected distance vision (20/32 or better) | 100% |
| Mean uncorrected distance vision | 20/24 |
| Uncorrected near vision (20/32 or better) | 92% |
| Mean uncorrected near vision | 20/26 |
| Best corrected distance vision (20/25 or better) | 100% |
| Patients reporting no halos | 100% |
| Patients reporting no glare | 79% |
| Corneal endothelial cell density | 2,475 cells/mm² |
Key Findings
- 100% of eyes with the third-generation lens achieved uncorrected distance vision of 20/32 or better.
- 92% of eyes achieved uncorrected near vision of 20/32 or better.
- No serious adverse events were reported during the 6-month follow-up.
- All eyes reached best corrected distance vision of 20/25 or better.
- 79% of patients reported no glare, with only 3% reporting moderate glare.
- Corneal endothelial cell density remained well-maintained at an average of 2,475 cells/mm².
Clinical Implications
The Z+ Virtual Aperture IOL shows results in providing a continuous range of vision with minimal visual disturbances.
Conclusion
The 6-month results for the Z+ Virtual Aperture IOL indicate visual outcomes and safety.
Related Resources & Content
- Z Optics, GlobeNewswire, 2026 -- Z Optics Presents Six-Month Clinical Results for the Z+
- The Ophthalmologist, 2026 -- Shape-Changing IOL Shows Durability
- Corneal Physician, 2022 -- Selecting an IOL
- Glaucoma Physician, 2023 -- Six-month Data Presented for SpyGlass Drug-eluting IOL
- ESCRS guideline for cataract surgery 2024: executive summary - PMC
- presbyopia physician — Small Aperture Technology Poised to Shake Up IOL Landscape
- Z Optics Presents Six-Month Clinical Results for the Z+
- ESCRS guideline for cataract surgery 2024: executive summary - PMC
- Comparative visual outcomes of extended depth-of-focus intraocular lenses after cataract surgery: a Bayesian network meta-analysis | BMC Ophthalmology | Springer Nature Link
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







